The U.S. Health Feds’ Effort to Purge Ivermectin Use is Working  

The U.S. Health Feds’ Effort to Purge Ivermectin Use is Working  

Recently, TrialSite reached out to 100 pharmacies in a survey investigating whether ivermectin would be available. Many readers have sent us tips that the supply of the drug was suddenly in very short supply. While ivermectin prescriptions skyrocketed by summer for off-label use driven by COVID-19, there were no pervasive reports of shortage or availability issues then. After reaching out to 100 pharmacies, TrialSite reports nearly 65% of them suddenly have major “supply issues” informing our analysts that the product was out and on backorder. 

Prescriptions for ivermectin absolutely skyrocketed to nearly 90,000 prescriptions per week, reported the New York Times last month even though the drug purportedly didn’t help address early-onset mild-to-moderate COVID-19. By October, TrialSite suggests increasing pressure from pharmacy and physician licensing boards on providers to not prescribe the drug for off-label use led to sweeping changes in access. Of course, the pressure comes from above as the current Biden administration, leadership within the National Institutes of Health and the U.S. Food and Drug Administration (FDA), and the media have vilified t...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee